Nvidia Gains After $20B Groq Licensing Deal for Inference AI

Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals and ImmuCell

  • Stocks rose midday Friday as U.S. markets reopened after the Christmas holiday, with the S&P 500 hitting a fresh high.
  • NVIDIA agreed to a non‑exclusive licensing deal for its inference technology valued at about $20 billion, lifting its shares nearly 2%.
  • Sidus Space, Coupang, Vanda Pharmaceuticals and ImmuCell all saw notable gains after company‑specific news.

U.S. equities traded higher midday Friday as investors returned after the Christmas holiday and the S&P 500 notched a new all‑time high. Markets showed modest ETF gains: the SPDR S&P 500 ETF (SPY) rose 0.08%, the Invesco QQQ Trust (QQQ) gained 0.16%, and the SPDR Dow Jones Industrial Average ETF Trust (DIA) climbed 0.01%.

- Advertisement -

Nvidia Corp. shares rose nearly 2% after the company entered a non‑exclusive licensing agreement with Groq for its inference technology, a deal valued at about $20 billion. Inference technology is software and models that run trained artificial‑intelligence systems to produce outputs from input data.

Sidus Space Inc. jumped more than 22% midday after the firm was awarded a contract under the Missile Defense Agency’s Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) program. SIDU stock has climbed about 237% over the past five trading sessions.

According to Reuters, Coupang Inc. rose over 9% after the company said that “all leaked customer information has been deleted”; Coupang stated the suspect was a former employee. CPNG is up roughly 10% over the past five trading sessions.

Vanda Pharmaceuticals Inc. gained nearly 8% in premarket trading before settling about 3% higher as investors awaited an upcoming U.S. Food and Drug Administration decision on Tradipitant, a motion‑sickness prevention drug. VNDA is up 7% over five sessions.

- Advertisement -

ImmuCell Corp. rose nearly 10% midday after announcing a 50% expansion of its First Defense field sales force and plans to scale up drug manufacturing; the company also said it is pausing its Re‑Tain treatment for cows after receiving an “Incomplete Letter” from the FDA. ICCC is up about 2% over the past five trading sessions.

✅ Follow BITNEWSBOT on Telegram, Facebook, LinkedIn, X.com, and Google News for instant updates.

Previous Articles:

- Advertisement -

Latest News

Bitfinex Hacker Ilya Lichtenstein Freed Early via First Step

Ilya Lichtenstein was released from prison after serving 14 months of a five-year sentence...

Waymo’s 2026 Expansion Could Drive Big Gains for GOOGL Surge

Alphabet rallied more than 60% in 2025 and enters 2026 with investor optimism tied...

Tesla shares slip as Q4 deliveries deemed largely neutral US

Tesla delivered 418,227 vehicles in Q4, slightly below the 422,850 company-polled consensus and last...

Institutions Pour In: 2026 Poised to Ignite ETH Value Rise!!

Ethereum insiders say 2026 could trigger significant ETH value growth as institutions increase on-chain...

EU Debates Digital Euro Privacy, Holding Limits: Compromises

The EU Council has endorsed the European Central Bank design for a digital euro...
- Advertisement -

Must Read

What Is Bcrypt Password Hashing Function?

KEY TAKEAWAYSBcrypt is a password hashing function that transforms plain passwords into unique alphanumeric sequences.It is a one-way process, ensuring that passwords cannot be...
Bitcoin (BTC) $ 89,989.00 2.05%
Ethereum (ETH) $ 3,124.47 4.59%
XRP (XRP) $ 1.99 6.57%
Bittensor (TAO) $ 246.06 8.34%
Polkadot (DOT) $ 2.10 5.72%
Cardano (ADA) $ 0.388157 9.96%
Chainlink (LINK) $ 13.28 6.71%
Hyperliquid (HYPE) $ 24.58 1.04%
Monero (XMR) $ 420.40 0.39%
Hedera (HBAR) $ 0.119865 6.41%
Toncoin (TON) $ 1.81 7.27%